Corium (CORI) Stock Rating Maintained by H.C. Wainwright; The $13.0000 Target Indicates 41.30% Potential; Independence Realty Trust (IRT) Has 1.37 Sentiment

June 19, 2018 - By Winifred Garcia

Independence Realty Trust Inc (IRT) investors sentiment increased to 1.37 in 2018 Q1. It’s up 0.07, from 1.3 in 2017Q4. The ratio is positive, as 82 funds increased or opened new positions, while 60 sold and trimmed equity positions in Independence Realty Trust Inc. The funds in our database now own: 66.47 million shares, up from 64.87 million shares in 2017Q4. Also, the number of funds holding Independence Realty Trust Inc in top ten positions was flat from 1 to 1 for the same number . Sold All: 13 Reduced: 47 Increased: 58 New Position: 24.

The firm have set TP of $13.0000 on Corium (NASDAQ:CORI) shares. This is 41.30% from the last stock price. In analysts note shared with investors on 15 June, H.C. Wainwright reaffirmed their Buy rating on shares of CORI.

Analysts await Independence Realty Trust, Inc. (NYSE:IRT) to report earnings on August, 7. They expect $0.19 earnings per share, 0.00% or $0.00 from last year’s $0.19 per share. IRT’s profit will be $16.63 million for 13.38 P/E if the $0.19 EPS becomes a reality. After $0.18 actual earnings per share reported by Independence Realty Trust, Inc. for the previous quarter, Wall Street now forecasts 5.56% EPS growth.

Orinda Asset Management Llc holds 8.2% of its portfolio in Independence Realty Trust, Inc. for 531,012 shares. Highland Capital Management Lp owns 2.15 million shares or 1.02% of their US portfolio. Moreover, Chilton Capital Management Llc has 0.91% invested in the company for 988,281 shares. The California-based Phocas Financial Corp. has invested 0.9% in the stock. Bard Associates Inc, a Illinois-based fund reported 185,100 shares.

Since January 1, 0001, it had 2 buys, and 0 sales for $145,775 activity.

Another recent and important Independence Realty Trust, Inc. (NYSE:IRT) news was published by Streetinsider.com which published an article titled: “Independence Realty Trust (IRT) Declares $0.18 Quarterly Dividend; 7.2% Yield” on June 10, 2018.

Independence Realty Trust, Inc is a real estate investment trust. The company has market cap of $889.65 million. The firm invests in the real estate markets of the United States. It has a 26.82 P/E ratio. It makes investments in apartment properties to create its portfolio.

The stock decreased 0.05% or $0.005 during the last trading session, reaching $10.165. About 239,466 shares traded. Independence Realty Trust, Inc. (IRT) has declined 1.76% since June 19, 2017 and is downtrending. It has underperformed by 14.33% the S&P500. Some Historical IRT News: ; 25/04/2018 – INDEPENDENCE REALTY TRUST INC – REITERATING ITS 2018 FULL YEAR GUIDANCE; 25/04/2018 – INDEPENDENCE REALTY TRUST INC IRT.N FY2018 FFO SHR VIEW $0.76 — THOMSON REUTERS l/B/E/S; 25/04/2018 – Independence Realty Trust 1Q Rev $45.6M; 22/04/2018 – DJ Independence Realty Trust Inc, Inst Holders, 1Q 2018 (IRT); 25/04/2018 – INDEPENDENCE REALTY TRUST INC QTRLY FFO PER SHARE $0.17; 25/04/2018 – INDEPENDENCE REALTY TRUST INC IRT.N SEES FY 2018 SHR $0.26 TO $0.31; 25/04/2018 – Independence Realty Trust 1Q EPS 4c; 07/03/2018 Revised Time for Independence Realty Trust’s Presentation at Citi 2018 Global Property CEO Conference; 25/04/2018 – Independence Realty Trust 1Q FFO 17c/Shr; 25/04/2018 – Independence Realty Trust Sees 2018 Core FFO 74c-79c/Share

The stock decreased 1.50% or $0.14 during the last trading session, reaching $9.2. About 60,805 shares traded. Corium International, Inc. (NASDAQ:CORI) has risen 23.07% since June 19, 2017 and is uptrending. It has outperformed by 10.50% the S&P500. Some Historical CORI News: 18/05/2018 – AGILE THERAPEUTICS INC – IN CRL, FDA INFORMED COMPANY THAT TWIRLA NDA COULD NOT BE APPROVED; 18/05/2018 – AGILE THERAPEUTICS INC – TO EXTENT THAT CO REFORMULATES TWIRLA, IT MAY CREATE NEED FOR ADDITIONAL MANUFACTURING WORK AND REVIEW BY FDA; 18/05/2018 – AGILE – FDA SAID CO NEEDS TO ADDRESS TWIRLA ADHESION PROPERTIES BY REFORMULATING TRANSDERMAL SYSTEM, CONDUCT FORMAL ADHESION STUDY WITH NEW FORMULATION; 30/04/2018 – Gilder Gagnon Howe Buys New 1.7% Position in Corium; 18/05/2018 – AGILE THERAPEUTICS – IN OFFICIAL MINUTES, FDA INFORMED CO IT CONTINUES TO HAVE SIGNIFICANT CONCERNS REGARDING ADHESION OF TWIRLA; 14/03/2018 – Abstract on AG200-15 (Twirla®) Accepted for Presentation at the APhA 2018 Annual Meeting & Exposition; 18/05/2018 – AGILE SAYS FDA COULD NOT APPROVE TWIRLA IN CRL; 18/05/2018 – Agile Therapeutics, Inc. Provides Regulatory Update on Twirla® (AG200-15) for the Prevention of Pregnancy; 18/05/2018 – AGILE THERAPEUTICSPROVIDES REGULATORY UPDATE ON TWIRLA; 18/05/2018 – AGILE THERAPEUTICS – FDA SAID AFTER CO SATISFIES QUESTIONS ON ADHESION, ADEQUATELY BRIDGES TO FINDINGS IN SECURE PHASE 3 TRIAL, IT ANTICIPATES DISCUSSING SAFETY & EFFICACY OF TWIRLA

Corium International, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of specialty pharmaceutical products in transdermal and transmucosal delivery systems. The company has market cap of $333.43 million. It offers Clonidine Transdermal Delivery System , a treatment for hypertension; Fentanyl TDS, a treatment for the management of chronic pain, including cancer-related pain; and Crest Whitestrips for teeth whitening. It currently has negative earnings. The companyÂ’s products under pipeline comprise Twirla, a combination hormonal contraceptive patch, which has completed Phase III clinical trial to deliver ethinyl estradiol and levonorgestrel hormones; MicroCor hPTH(1-34), a transdermal system that has completed Phase 1 and Phase II a clinical trial for the treatment of severe osteoporosis; and Donepezil and Memantine transdermal systems, which completed Phase I clinical trial for the treatment of Alzheimer's disease.

Analysts await Corium International, Inc. (NASDAQ:CORI) to report earnings on August, 2. They expect $-0.39 earnings per share, up 9.30% or $0.04 from last year’s $-0.43 per share. After $-0.50 actual earnings per share reported by Corium International, Inc. for the previous quarter, Wall Street now forecasts -22.00% EPS growth.

More notable recent Corium International, Inc. (NASDAQ:CORI) news were published by: Seekingalpha.com which released: “An Update On Corium International” on June 15, 2018, also Globenewswire.com with their article: “Corium to Present at the Jefferies 2018 Global Healthcare Conference” published on May 24, 2018, Nasdaq.com published: “Corium Announces Issuance of Key US Patent Covering Corplexâ„¢ Donepezil Transdermal System for Alzheimer’s …” on June 13, 2018. More interesting news about Corium International, Inc. (NASDAQ:CORI) were released by: Nasdaq.com and their article: “New Research Coverage Highlights Monolithic Power, Ulta Beauty, Twenty-First Century Fox, Corium International …” published on June 11, 2018 as well as Investingnews.com‘s news article titled: “Corium Announces Issuance of Key US Patent Covering Corplex Donepezil Transdermal System for Alzheimer’s Disease” with publication date: June 13, 2018.

Among 7 analysts covering Corium International (NASDAQ:CORI), 6 have Buy rating, 0 Sell and 1 Hold. Therefore 86% are positive. Corium International has $20 highest and $800 lowest target. $14’s average target is 52.17% above currents $9.2 stock price. Corium International had 29 analyst reports since August 25, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Wednesday, December 27 by H.C. Wainwright. The stock of Corium International, Inc. (NASDAQ:CORI) earned “Buy” rating by Zacks on Tuesday, August 25. Jefferies maintained Corium International, Inc. (NASDAQ:CORI) on Friday, May 26 with “Buy” rating. On Friday, October 27 the stock rating was maintained by Jefferies with “Buy”. The rating was maintained by Cantor Fitzgerald with “Buy” on Thursday, March 8. WBB Securities downgraded Corium International, Inc. (NASDAQ:CORI) rating on Monday, August 31. WBB Securities has “Hold” rating and $11 target. Needham maintained it with “Buy” rating and $16 target in Monday, November 16 report. The firm has “Buy” rating by Cantor Fitzgerald given on Friday, February 9. Cantor Fitzgerald maintained Corium International, Inc. (NASDAQ:CORI) on Thursday, November 16 with “Buy” rating. The stock of Corium International, Inc. (NASDAQ:CORI) has “Buy” rating given on Monday, July 17 by Jefferies.

Independence Realty Trust, Inc. (NYSE:IRT) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>